ResearcherMagna Graecia UniversityNo recent work listed

Domenico Ciliberto

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1830-7070; OpenAlex author ID A5037451718. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper

Papers 2

Systematic review and meta-analysis on targeted therapy in advanced pancreatic cancer. Co-author DOI 10.1016/j.pan.2016.01.003 ↗
Role of gemcitabine-based combination therapy in the management of advanced pancreatic cancer: a meta-analysis of randomised trials. Co-author DOI 10.1016/j.ejca.2012.08.019 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Pierosandro Tagliaferri · 2 shared papers, 2013–2016 · strength 0.11
- Paper Systematic review and meta-analysis on targeted therapy in advanced pancreatic cancer. DOI 10.1016/j.pan.2016.01.003 ↗
- Paper Role of gemcitabine-based combination therapy in the management of advanced pancreatic cancer: a meta-analysis of rando… DOI 10.1016/j.ejca.2012.08.019 ↗
Michele Caraglia · 1 shared paper, 2013 · strength 0.04
- Paper Role of gemcitabine-based combination therapy in the management of advanced pancreatic cancer: a meta-analysis of rando… DOI 10.1016/j.ejca.2012.08.019 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.